. . . " cannabis treatments at a wide range of dosage in order to balance potential side effects with maximum therapeutic benefit.Finally, there is evidence that cannabinoids may provide neuroprotective and anti-inflammatory benefits in MS. Neuroinflammation, found in autoimmune diseases such as MS, has been shown to be reduced by cannabinoids through the regulation of cytokine levels in microglial cells" .